Dr. Bassem Mounir Chehab, MD

Dr. Chehab practices at Ascension Via Christi St. Francis in Wichita, Kansas, part of Ascension Health Alliance.

Dr. Chehab's NPI, 1710006820, was assigned on March 28, 2007. Dr. Chehab holds Kansas license 04-33223.

Dr. Chehab's primary practice is Ascension Via Christi St. Francis, at 929 North St Francis Street, Wichita, KS 67214 in Sedgwick County. The practice phone is (316) 268-5000.

Dr. Chehab's primary practice is Ascension Via Christi St. Francis in Wichita, Kansas, part of Ascension Health Alliance. Dr. Chehab is also affiliated with Kansas Heart Hospital. The medical group on file is Ascension Medical Group Via Christi on Murdock. Dmand AI also links Dr. Chehab to 3 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chehab practices, 8 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Chehab's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Chehab is licensed in Kansas.

CMS data shows 10,255 Medicare services from Dr. Chehab across 43 procedure codes in 2024, for 2,168 Medicare patients. Medicare paid $836,318 for them.

CMS counts 2,168 Medicare patients who saw Dr. Chehab in 2024. The largest group is 75 to 84, with 863 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.48, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Chehab's median patient age at 75, with 49% women.

In 2024, Dr. Chehab wrote 9,111 Medicare Part D claims for 1,311 patients. 87% of them were for generic drugs. CMS names the drug for 8,898 of them, across 47 drugs with 11 or more claims each, at $1,054,811 in total drug cost. In 2023, CMS named 8,107 claims across 44 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 68 out of 100 for Dr. Chehab for performance year 2024, reported individually. Dr. Chehab accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 110 procedures of coronary angioplasty and stenting by Dr. Chehab, more than 97% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 27 papers to Dr. Chehab, published from 2011 to 2025. 2023 was the busiest year, with 4. The most frequent topics are Percutaneous Coronary Intervention, Drug-Eluting Stents and Hemorrhage. Dr. Chehab has published most often in EuroIntervention. Dr. Chehab's most frequent co-authors are Aziz R. Maksoud, MD, Dominick Joseph Angiolillo, MD and James B. Hermiller, MD.

Dmand AI links Dr. Chehab to 10 clinical trials. 7 are still active or recruiting. Conditions studied include Heart Valve Diseases, Mitral Valve Insufficiency and Ventricular Outflow Obstruction. Abbott Medical Devices sponsors the most, 6.

CMS Open Payments shows 1,536 general payments to Dr. Chehab from 32 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 57% of the total. Abbott Laboratories paid the most, $314,376. It also lists 1 research payment totaling $1,000 in 2019.